Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. But as Peter Lynch said in One Up On Wall ...
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see BioSyent Inc. (CVE:RX) is about to trade ex-dividend in the next 4 days. The ex-dividend date ...
Pursuant to the SPA, BioSyent will acquire from the shareholders of Oral Science (the "Sellers”), in an arm’s length transaction, 100% of the issued and outstanding shares of Oral Science Inc. for a ...
TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- This press release is being disseminated as required by National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting ...
For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk of stock picking is that you will likely buy under-performing companies. We ...
BioSyent ( CVE:RX ) Full Year 2024 Results Key Financial Results Revenue: CA$35.0m (up 11% from FY 2023). Net income... MISSISSAUGA, Ontario, March 13, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc.
(RTTNews) - BioSyent Inc. (BIOYF, RX.V) has entered into a Share Purchase Agreement to acquire Oral Science Inc., a privately-owned Canadian dental company, for $25.5 million, in a share and cash deal ...
Completed acquisition of Oral Science Inc., a Canadian owner and distributor of specialized dental hygiene and oral health products, as announced on March 2, 2026 Additional sales and EBITDA of $2,984 ...
MISSISSAUGA, Ontario, Oct. 05, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce the introduction of FeraMAX ® Pd, a new oral iron supplement ...
MISSISSAUGA, Ontario, April 30, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2025 Bloom Burton & Co.
MISSISSAUGA, Ontario, Jan. 30, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results